SCHEMBL19804599

SCHEMBL19804599

C/C=C/C(=O)OCc1cc(C2CCCCC2)ccc1-c1ccc(OCCO)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 4/20 0.46
PPARG P37231 2/20 0.38
PPARA Q07869 1/20 0.38
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
GPR35 Q9HC97 1/20 0.36
HRH3 Q9Y5N1 2/20 0.35
KCNH2 Q12809 1/20 0.35
GSTP1 P09211 1/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 1/20 0.35
APP P05067 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
CSF1R P07333 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19624418 0.91 FFAR4 (0.41) FFAR4RAB9AHRH3GSTP1CSF1R
SCHEMBL19796909 0.86 FFAR4 (0.39) FFAR4PPARGPPARARAB9A
SCHEMBL19804771 0.82 FFAR4 (0.48) FFAR4PPARGPPARAMEN1NPC1
SCHEMBL19804023 0.81 FFAR4 (0.42) FFAR4MEN1RAB9AKMT2AGSTP1
SCHEMBL19804576 0.80 FFAR4 (0.48) FFAR4PPARGPPARAMEN1NPC1
SCHEMBL19804799 0.79 FFAR4 (0.45) FFAR4PPARGPPARAPOLBHRH3
SCHEMBL19804664 0.78 FFAR4 (0.42) FFAR4PPARGPPARAPOLBRAB9A
SCHEMBL19804766 0.78 FFAR4 (0.49) FFAR4PPARGPPARAPOLBRAB9A
SCHEMBL19796454 0.78 FFAR1 (0.39) FFAR4MEN1KMT2ACYP3A4SMN1; SMN2
SCHEMBL19804804 0.77 FFAR4 (0.42) FFAR4PPARGPPARAMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 FFAR4 1715/4885PPARG 3314/4885PPARA 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.